nus, 600 and 450 ms) and two right ventricular sites (apex and outflow tract). A sustained ventricular tachyarrhythmia was induced in 23 patients (40%) and a nonsustained ventricular tachycardia in 14 patients (24%). Induction of sustained tachycardia correlated with the presence of akinesia or aneurysm, or both, by radionuclide angiography, but not with ejection fraction or presence or absence of coronary artery disease.
These results indicate that: 1) patients with clinical nonsustained ventricular tachycardia and chronic left ventricular dysfunction have a high incidence of inducible sustained ventricular tachycardia or ventricular fibrillation; and 2) electrophysiologic testing may allow further substratification of risk of sudden cardiac death in high risk patients with nonsustained ventricular tachycardia.
(J Am Coli CardioI1985; 6:31-9) mortality rate. A similarly high risk of sudden death has been demonstrated for patients with nonsustained ventricular tachycardia and chronic left ventricular dysfunction (6) . The purpose of this study was to use programmed ventricular stimulation to test the vulnerability of patients with chronically poor left ventricular function and clinically documented nonsustained ventricular tachycardia to sustained and potentially life-threatening ventricular tachyarrhythmias.
Methods
Definitions. To establish inclusion criteria for this study, the following definitions were used: 1) abnormal left ventricular function was defined as an ejection fraction less than 50% by radionuclide angiography using either a first pass or gated technique; and 2) nonsustained ventricular tachy-cardia was defined as three or more complexes but less than 15 seconds of self-terminating ventricular tachycardia by 24 hour ambulatory electrocardiographic [Holter] or telemetric monitoring. It was required that the arrhythmia occur in the absence of antiarrhythmic drugs, acute ischemia, recent «3 months) myocardial infarction, long QT syndrome or electrolyte abnormalities. Patients with prior documented cardiac arrest or sustained ventricular tachycardia, even if present only during treatment with antiarrhythmic medications, were excluded. Patients were not excluded for neurologic symptorris unless these were associated with a documented sustained arrhythmia or cardiac arrest.
Study patients. The study group consisted of 58 patients. There were 47 men and 11 women ranging in age from 28 to 78 years (mean 61). Cardiac catheterization was performed in 21 patients. Clinical diagnoses included coronary artery disease in 28 patients (confirmed by coronary angiography in II patients or by the presence of a documented myocardial infarction or a history of classic angina in 17 patients), congestive cardiomyopathy in 22, valvular heart disease in 6 and combined valvular and coronary artery disease in 2. Thirty-six (62%) of the patients had no symptoms associated with their arrhythmia, 13 had transient palpitation, 5 had dizziness, 3 had syncope and I had transient chest pain. Mean ejection fraction for the group was 27% (range 8 to 48) and mean cardiac index calculated from the radionuclide angiograms was 2.6 liters/min per m 2 (range 1.4 to 5.2). Sixteen of the 28 patients with coronary artery disease had at least one akinetic or dyskinetic ventricular segment by radionuclide angiography. Before electrophysiologic testing, 48 (82%) of the 58 patients had been treated empirically with one to five antiarrhythmic medications, including type IA agents in 34 patients, phenytoin in 10 and experimental drugs in 4.
Arrhythmia documentation. The presence of nons ustained ventricular tachycardia, while the patients were not receiving any antiarrhythmic medications, was documented by complete 24 hour Holter monitor recordings in 45 patients (78%) and by telemetric monitoring in the remaining 13 patients. Of the patients with full Holter monitor data, 50% had 1 to 10 occurrences of nonsustained ventricular tachycardia, 23% had between 10 and 100 occurrences and 27% had more than 100 occurrences. The mean number of complexes in the longest run of non sustained ventricular tachycardia was 6 (range 3 to 25). The mean upper rate of the tachycardia was 151 beats/min (range 100 to 200). Mean ventricular premature complex frequency was 504/h with a wide range of between 1 to 2,162. Thirty-five (81%) of the patients had more than 100 ventricular premature complexes/h and 41 (96%) had couplets.
Electrophysiologic testing. Programmed ventricular stimulation was performed in the postabsorptive state after informed written consent was obtained and antiarrhythmic medications had been discontinued for at least five halflives. Three multipOlar electrode catheters were inserted percutaneously or by cutdown and positioned under fluoroscopic guidance in the high right atrium, at the A V junction in the His bundle position and at the right ventricular apex. The right ventricular apical catheter was later repositioned in the right ventricular outflow tract in those patients in whom sustained arrhythmia was not induced at the right ventricular apex. Stimulation was performed using a custom-designed programmable stimulator with optically isolated constant-current sources (Bloom Associates, Ltd.) set to produce rectangular pulses 1 ms in duration and twice diastolic threshold. Threshold was always less than 2 rnA. Three electrocardiographic leads (I, II and V,) were recorded along with bipolar intracardiac electrograms from each site filtered at 30 to 500 Hz. All recordings were simultaneously displayed on a multichannel oscilloscope (Electronics for Medicine VR 16) and recorded on magnetic tape (Honeywell 5600) for subsequent retrieval on photographic paper. Real-time records were also obtained with an inkjet recorder (Mingograph, Siemens Elema) at paper speeds of 100 to 200 ri:un/s.
In each case the stimulation protocol included the introduction of single, double and triple ventricular extrastimuli during sinus rhythm and two paced ventricular cycle lengths (S,S,) of 600 and 450 ms at both the right ventricular apex and right ventricular outflow tract. Ventricular extrastimuli were introduced beginning in late diastole at the right ventricular apex first and were moved progressively earlier in 10 to 20 ms decrements until ventricular refractoriness was achieved. If a single extrastimulus (S2) did not result in initiation of a sustained tachycardia, a second extrastimulus (S3) was added. The S,S2 interval was reset to 50 to 100 ms greater than the ventricular effective refractory period and the S2S3 interval was programmed to equal the S, S2 interval. The S2S3 interval was progressively decremented by 10 to 20 ms until S3 became refractory, at which time S2 was decreased by the same amount until S3 again evoked a response. This sequence was continued until S2 was again refractory or until sustained tachycardia was initiated. If double extrastimuli failed to evoke a sustained arrhythmia, then a third extrastimulus (S4) was added and the protocol was repeated as just described.
If stimulation at the right ventricular apex did not result in a sustained tachycardia, the entire protocol was repeated at the right ventricular outflow tract. In no patient was isoproterenol infusion or left ventricular stimulation utilized. The stimulation sequence was prematurely terminated only for the initiation of a sustained ventricular tachyarrhythmia.
Three categories of response to ventricular stimulation were defined: 1) An arrhythmia was considered to be not inducible if there were fewer than six repetitive responses to programmed stimulation. 2) Nonsustained ventricular tachyarrhythmia was defined as six or more complexes but less than 15 seconds of self-terminating monomorphic or polymorphic ventricular tachycardia or ventricular fibrillation. 3) Sustained ventricular tachyarrhythmia was defined as at least 15 seconds of inducible monomorphic or polymorphic ventricular tachycardia or ventricular fibrillation or a tachycardia requiring cardioversion in less than 15 seconds as a result of hemodynamic collapse.
Statistical analysis. Comparisons among the three induced arrhythmia subsets were made using standard statistical techniques, including R x C contingency tables and Fisher's exact test for dichotomous variables and analysis ( Table IA) . Typical Holter monitor strips and intracardiac recordings on one such patient are shown in Figures I and  2 . Ventricular tachycardia with a sustained uniform configuration was induced in IS patients and ventricular flutter or fibrillation in 8 patients. Double ventricular extrastimuli induced the arrhythmia in 9 patients and triple ventricular extrastimuli in 14 patients. The mean cycle length for all tachycardias excluding ventricular fibrillation was 235 ms (range ISO to 340). Cardioversion was required for termination of the arrhythmia in 16 patients. Burst pacing was effective for termination in six patients, and in one patient the tachycardia terminated spontaneously. There was no consistent correlation in rate or configuration between the spontaneous nonsustained ventricular tachycardia and the induced sustained tachyarrhythmia in these patients. Nonsustained ventricular tachycardia was induced in 14 patients (Table IB) . Figures 3 and 4 show typical Holter monitor and intracardiac recordings from one of these patients. The tachycardia was polymorphic in IS patients and JACC Vol. 6, No. I July 1985: uniform in configuration in only 2 patients. Double ventricular extrastimuli initiated the tachycardia in seven patients and triple ventricular extrastimuli in the remaining seven patients. Individual episodes ranged in duration from 9 to 46 complexes (mean 22). The cycle lengths of each tachycardia, denoted as the shortest and longest RR intervals, varied widely between 160 and 330 ms. By definition, the tachycardias terminated spontaneously in all cases. As in the patients with inducible sustained ventricular tachycardia and as typified by a comparison of Figures 3 and 4 , there was no consistent correlation in tate or configuration between the spontaneous and induced nonsustained ventricular tachycardias.
No arrhythmia was inducible in 21 patients despite completion of the full stimulation protocol at both right ventricular sites ( Fig. 5 and 6 ).
Correlation between clinical data and induced arrhythmias (Table 2) . To determine whether the induction of a specific arrhythmia could be predicted from available clinical data, baseline clinical information was compared in the three induced arrhythmia subsets using standard contingency table analysis and analysis of variance techniques as indicated. There was no significant difference in age, sex, sytnptoms (including evidence of syncope), prior drug usage, ejection fraction or presence or absence of coronary artery disease in the three groups. Similarly, no Holter recording abnormality allowed separation of the groups. However, the presence of an akinetic or aneurysmal segment, or both, by radionuclide angiography was significantly greater in patients in whom a sustained ventricular tachyarrhythmia was initiated as compared with the two other groups (sensitivity -l<'igure 3. Holter monitor tracing from a patient with inducible non sustained ventricular tachycardia, This strip shows the longest run of nonsustained ventricular tachycardia in this patient, who had ischemic heart disease and an ejection fraction of 17%. The tachycardia was uniform in configuration at a rate of 136 beats/min. 48%, specificity 86%), The positive predictive value for akinesia or aneurysm, that is, the likelihood that a patient with such contraction abnormalities would have a sustained ventricular tachyarrhythmia induced, was 69%, Patients without an akinetic or aneurysmal segment, however, still had a 29% chance of having an inducible sustained arrhythmia, Finally, patients with inducible nonsustained ventricular tachycardia had significantly less contraction abnormality than those in the other two groups.
Discussion
Previous studies. This study demonstrates that sus- studies found that a subset of their population with an abnormal ejection fraction had an increased incidence of inducible sustained ventricular tachyarrhythmias, In the study by Gomes et al. (7), 20 patients had inducible arrhythmias, including sustained ventricular tachycardia in 8, ventricular fibrillation in 5 and non sustained ventricular tachycardia in 7. Seventeen of these patients had an ejection fraction of 40% or less, In the study by Buxton et al. (8) , 15 patients had inducible sustained ventricular tachycardia, 9 of whom had an ejection fraction of 40% or less. In our study, only those patients with nonsustained ventricular tachycardia in the setting of depressed ventricular function were considered for electrophysiologic testing, We chose this group for evaluation because previous studies (3-6) have shown, both for acute and chronic organic heart disease, that such patients are at high risk for sudden cardiac death. In contrast, patients with nonsustained ventricular tachycardia and normal ventricular function have a normal or near normal life expectancy, In an analysis of 430 patients after acute myocardial infarction, for example, Bigger et al. (5) found triplets or longer runs of ectopic activity by Holter monitoring in 50 patients (11.6%). These patients subsequently had a 38% 1 year and a 54% 3 year sudden death mortality rate. In 37 patients with chronic organic heart disease and nonsustained ventricular tachycardia by Holter monitor recording, Follansbee et al. (6) found a 47% incidence of sudden death JACC Vol. 6. No. I
July 1985: during a I year follow-up period in patients with congestive heart failure, as opposed to a 6% mortality rate in patients without heart failure. Because the primary event for the vast majority of patients who die suddenly is sustained ventricular tachyarrhythmia, electrophysiologic testing with programmed ventricular stimulation as performed here may allow further substratification of risk in such high risk patients. A similar approach was used by Richards et al. (9) in studying patients after acute myocardial infarction. It is of interest that the mean cycle length of induced ventricular tachycardia in our patients was 235 ms, which was rapid enough to account for hemodynamic collapse and require cardioversion for termination of the arrhythmia in 16 (70%) of the 23 patients in the subgroup with sustained tachyarrhythmia. This is consistent with clinical data from other studies on resuscitated patients, such as the Seattle Heart Watch (10,11), in which less than 10% of patients have a hemodynamically tolerated sustained ventricular tachycardia at the time of arrival of a rescue squad.
Electrophysiologic considerations. The stimulation protocol used in this study is our standard laboratory protocol for patients with ventricular tachyarrhythmias and was entirely consistent from patient to patient. No patient was studied using currents greater than twice diastolic threshold. Left ventricular stimulation and isoproterenol infusion were specifically avoided because they could not be uniformly applied to the entire patient group. The use of a second right ventricular site and triple ventricular extrastimuli have been a routine part of our laboratory protocol for several years in patients with documented or suspected sustained ventricular tachyarrhythmias. Such methods clearly increase the sensitivity of electrophysiologic testing; whether specificity is significantly altered remains a debated issue (12) (13) (14) . Brugada et aL (13) showed that in some patients without clinically documented ventricular arrhythmias, such arrhythmias could still be induced in the electrophysiology laboratory, especially with aggressive stimulation protocols including three and four extrastimuli, However, using the same protocol as in our study, the most common arrhythmia induced by Brugada and coworkers was polymorphic nonsustained ventricular tachycardia lasting less than 10 complexes, Ventricular fibrillation was rarely induced and monomorphic sustained ventricular tachycardia was never induced, Moreover, the study included 17 patients with moderate to severe organic heart disease in whom a predisposition to ventricular arrhythmias would not be unexpected, Therefore, the induction in 31 % of our patients of monomorphic sustained ventricular tachycardia is unlikely to be artifactuaL In addition, among the 14 patients in our study with induction of polymorphic non sustained ventricular tachycardia, the arrhythmia was initiated by double ventricular extrastimuli in 50% and had a duration significantly greater than the apparently artifactual responses reported by Brugada et ai, (13) . Still, the specificity of induced polymorphic non sustained ventricular tachycardia in our patient group will need to be established by further studies and long-term follow-up data.
Correlations with clinical data. Significantly, the subgroups with induced arrhythmia could not have been predicted from any Holter monitor criteria including number of occurrences of ventricular tachycardia, rate, longest run, presence of other degrees of complexity or ventricular premature complex frequency. This is in agreement with prior epidemiologic data from Bigger et aL (5) in patients with nonsustained ventricular tachycardia after acute infarction, which showed no correlation between the number of episodes of non sustained ventricular tachycardia or the length of the tachycardia runs and mortality in a year or more of follow-up study. / There was also no relation between the severity of depression of ejection fraction or the presence or absence of coronary artery disease and induced arrhythmia.
However, a correlation was found between the presence of a severe contraction abnormality, as assessed by radionuclide angiography, namely, akinesia or aneurysm, or both, and the ability to induce a sustained tachyarrhythmia. Eleven (69%) of the 16 patients with an akinetic or aneurysmal segment, or both, had an inducible sustained arrhythmia as compared with 29% without such abnormality. These data suggest that the presence of scar is a more important determinant of the ability to sustain a life-threatening tachyarrhythmia than is ischemia or abnormal ventricular function. A great deal of experimental and clinical data support such a contention (15) (16) (17) (18) (19) . The vast majority of patients previously reported to have sustained ventricular tachycardia have had a ventricular aneurysm anatomically. Even in patients with ventricular tachycardia after repair of tetralogy of Fallot who are without ischemic heart disease, ventricular Correlation with clinical configuration and rate of tachycardia. Although Buxton et aL (8) reported initiation of a ventricular tachycardia that resembled the spontaneous arrhythmia in 63% of their patients with non sustained ventricular tachycardia, this was not the case in our patients. In fact, we found little correlation between the rate and configuration of the clinical nonsustained ventricular tachycardia seen on Holter monitoring or telemetry and the induced sustained or nonsustained ventricular tachycardia in the laboratory. This is not surprising because:· I ) the electrocardiographic lead system used to monitor patients during electrophysiologic study frequently differs from the lead configuration used to record Holter monitor or telemetry data, thereby making comparisons of configuration highly suspect; and 2) nonsustained ventricular tachycardia by Holter monitor is frequently variable in rate and configuration within the same run or between runs in patients with multiple episodes (25, 26) . Moreover, such comparisons hardly seem relevant to the 40% of patients in whom a sustained tachyarrhythmia was induced. We believe that, in contrast to patients with clinical episodes of recurrent sustained ventricular tachycardia in whom the purpose of the laboratory protocol is to initiate the clinical arrhythmia and then test antiarrhythmic drug therapy, in patients with poor ventricular function, nonsustained ventricular tachycardia is a marker for the abnormal electrophysiologic milieu necessary to alIowa sustained tachyarrhythmia to develop. Thus, the goal of electrophysiologic testing in this group is simply to expose a latent abnormality, not reproduce a clinical arrhythmia. Conceptually, this approach is similar to that of Richards et aL (9) in patients studied after acute myocardial infarction.
Limitations and recommendations. Electrophysiologic
testing has proved to be of value in the selection of antiarrhythmic drug and pacemaker or surgical therapy for patients with clinical episodes of sustained ventricular tachyarrhythmias (18, (27) (28) (29) (30) (31) . However, in patients who are at high risk for sudden cardiac death but who have not yet developed a clinical sustained tachyarrhythmia, the role of electrophys-iologic testing in further defining risk remains to be established (7, 9, (32) (33) (34) (35) . In patients after acute myocardial infarction, there is increasing evidence that such studies will enable the identification of those patients who will subsequently develop a life-threatening arrhythmia (9, 32, 33) .
In our study we have examined a second group at increased risk for sudden cardiac death, namely, those patients with chronically poor left ventricular function and clinical episodes of non sustained ventricular tachycardia. However, we do not propose that it is yet sensible to assume that only those patients in whom sustained ventricular tachyarrhythmias were induced should be treated aggressively and the other subgroups ignored. For the findings of this study (or any study that addresses the use of stimulation techniques to predict future arrhythmia development) to have full meaning and a role for electrophysiologic testing in such patients to be secured, one of three approaches must be taken: 1) all patients must be randomized on the basis of the results of their initial study to different treatment methods and followed up for outcome; 2) all patients must be treated aggressively using electrophysiologic techniques after their baseline study and the results must be compared with those of a control group with nonsustained ventricular tachycardia and abnormal ventricular function receiving no therapy or "standard care;" or 3) all patients must be followed up while receiving no antiarrhythmic medications after their initial electrophysiologic evaluation. Although the last choice is clearly preferable scientifically, it is the most difficult option to pursue ethically and practically in the United States. Therefore, it is likely that the first and second options will help determine the true value of stimulation techniques in such high risk patients.
